GlassScriptPhysician profile
Amr Sayed Morsy
NPI 1447233895
$18,259.63
in general payments reported to CMS, 2019-2025
52 companies · $3,240 in 2025
The $3,240 reported for 2025 was more than what 86% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,763 · 2020: $1,226 · 2021: $1,708 · 2022: $4,155 · 2023: $2,444 · 2024: $2,724 · 2025: $3,240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,782 · Travel and Lodging: $1,625.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,782.31 |
| Travel and Lodging | $1,624.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,531.58 | 2019-2025 | Proclaim, Eterna |
| Medtronic, INC. | $3,019.53 | 2021-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Spinal Simplicity, LLC | $2,121.36 | 2022-2025 | Ha Minuteman G3-R |
| Abbvie INC. | $1,083.92 | 2021-2025 | |
| Stryker Corporation | $931.95 | 2025 | Mild Device Kit |
| Scilex Pharmaceuticals INC. | $856.22 | 2019-2025 | Ztlido |
| Collegium Pharmaceutical, INC. | $825.77 | 2019-2025 | Xtampza |
| Medtronic USA, INC. | $612.98 | 2019-2020 | |
| Vertos Medical, INC. | $576.16 | 2019-2023 | Mild Device Kit |
| Nevro Corp. | $562.59 | 2019-2024 | Senza |
| Pfizer INC. | $459.88 | 2019-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $402.81 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $356.16 | 2019-2023 | Ajovy |
| Grt US Holding, INC. | $344.04 | 2020-2022 | |
| Bioventus LLC | $257.61 | 2020-2025 | Durolane, Gelsyn-3, Supartz Fx Sodium Hyaluronate |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amr Morsy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.